Table of Contents
1. Preface
2. Assumptions and Research Methodology
3. Executive Summary
4. Market Overview
5. Market Dynamics
6. Market Analysis, by Treatment
- 6.1. Surgical
- 6.1.1. Surgical Excision
- 6.1.2. Electrodessication & Cutterage (ED&C)
- 6.1.3. Moh's Surgery
- 6.1.4. Cryosurgery
- 6.2. Drugs
- 6.2.1. Topical Treatment
- 6.2.2. Advanced Medication
- 6.2.3. Other
- 6.3. Others
- 6.3.1. Radiation Therapy
- 6.3.2. Photodynamic Therapy (PDT)
- 6.3.3. Laser Therapy
7. Market Analysis, by End-user
- 7.1. Hospitals
- 7.2. Specialty Clinics
- 7.3. Others
8. Market Analysis, by Region
- 8.1. North America
- 8.2. Europe
- 8.3. Asia Pacific
- 8.4. Latin America
- 8.5. Middle East & Africa
9. North America Market Analysis
10. Europe Market Analysis
11. Asia Pacific Market Analysis
12. Latin America Market Analysis
13. Middle East & Africa Market Analysis
14. Company Profiles
- 14.1. Sun Pharmaceuticals Ltd.
- 14.2. Valeant Pharmaceuticals International, Inc.
- 14.3. Mylan N.V.
- 14.4. F. Hoffmann-La Roche Ltd.
- 14.5. Merck & Co., Inc.
List of Tables
Table 01: Global Market Size (US$ Mn) Forecast, by Treatment, 2023 to 2033
Table 02: Global Market Size (US$ Mn) Forecast, by Surgical Treatment, 2023 to 2033
Table 03: Global Market Size (US$ Mn) Forecast, by Drugs Treatment, 2023 to 2033
Table 04: Global Market Size (US$ Mn) Forecast, by Other Treatment, 2023 to 2033
Table 05: Global Market Size (US$ Mn) Forecast, by End-user, 2023 to 2033
Table 06: Global Market Size (US$ Mn) Forecast, by Region, 2023 to 2033
Table 07: North America Market Size (US$ Mn) Forecast, by Treatment, 2023 to 2033
Table 08: North America Market Size (US$ Mn) Forecast, by Surgical Treatment
Table 09: North America Market Size (US$ Mn) Forecast, by Drugs Treatment
Table 10: North America Market Size (US$ Mn) Forecast, by Other Treatment
Table 11: Global Market Size (US$ Mn) Forecast, by End-user, 2023 to 2033
Table 12: North America Market Size (US$ Mn) Forecast, by Country, 2023 to 2033
Table 13: Europe Market Size (US$ Mn) Forecast, by Treatment, 2023 to 2033
Table 14: Europe Market Size (US$ Mn) Forecast, by Surgical Treatment, 2023 to 2033
Table 15: Europe Market Size (US$ Mn) Forecast, by Drugs Treatment, 2023 to 2033
Table 16: Europe Market Size (US$ Mn) Forecast, by Other Treatment, 2023 to 2033
Table 17: Europe Market Size (US$ Mn) Forecast, by End-user, 2023 to 2033
Table 18: Europe Market Size (US$ Mn) Forecast, by Country, 2023 to 2033
Table 19: Asia Pacific Market Size (US$ Mn) Forecast, by Treatment, 2023 to 2033
Table 20: Asia Pacific Market Size (US$ Mn) Forecast, by Surgical Treatment
Table 21: Asia Pacific Market Size (US$ Mn) Forecast, by Drugs Treatment, 2023 to 2033
Table 22: Asia Pacific Market Size (US$ Mn) Forecast, by Other Treatment, 2023 to 2033
Table 23: Asia Pacific Market Size (US$ Mn) Forecast, by End-user, 2023 to 2033
Table 24: Asia Pacific Market Size (US$ Mn) Forecast, by Country, 2023 to 2033
Table 25: Latin America Market Size (US$ Mn) Forecast, by Treatment, 2023 to 2033
Table 26: Latin America Market Size (US$ Mn) Forecast, by Surgical Treatment
Table 27: Latin America Market Size (US$ Mn) Forecast, by Drugs Treatment
Table 28: Latin America Market Size (US$ Mn) Forecast, by Other Treatment
Table 29: Latin America Market Size (US$ Mn) Forecast, by End-user, 2023 to 2033
Table 30: Latin America Market Size (US$ Mn) Forecast, by Country, 2023 to 2033
Table 31: Middle East & Africa Market Size (US$ Mn) Forecast, by Treatment
Table 32: Middle East & Africa Market Size (US$ Mn) Forecast, by Surgical Treatment, 2023 to 2033
Table 33: Middle East & Africa Market Size (US$ Mn) Forecast, by Drugs Treatment, 2023 to 2033
Table 34: Middle East & Africa Market Size (US$ Mn) Forecast, by Other Treatment, 2023 to 2033
Table 35: Middle East & Africa Market Size (US$ Mn) Forecast, by End-user
Table 36: Middle East & Africa Market Size (US$ Mn) Forecast, by Country, 2023 to 2033
List of Figures
Figure 01: Market Snapshot
Figure 02: Global Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2023 to 2033
Figure 03: Market Value Share by Treatment (2022)
Figure 04: Market Value Share by End-user (2022)
Figure 05: Market Value Share by Region (2022)
Figure 06: Global Market Value Share Analysis, by Treatment, 2022 and 2033
Figure 07: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Surgical Treatment, 2023 to 2033
Figure 08: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Drugs Treatment, 2023 to 2033
Figure 09: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2023 to 2033
Figure 10: Global Market Attractiveness Analysis, by Treatment
Figure 11: Global Market Value Share Analysis, by End-user, 2022 and 2033
Figure 12: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2023 to 2033
Figure 13: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Specialty Clinics, 2023 to 2033
Figure 14: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2023 to 2033
Figure 15: Global Market Attractiveness Analysis, by End-user
Figure 16: Global Market Value Share Analysis, by Region, 2022 and 2033
Figure 17: Global Market Attractiveness Analysis, by Region
Figure 18: North America Market Size (US$ Mn) Forecast, 2023 to 2033
Figure 19: North America Market Attractiveness Analysis, by Country
Figure 20: North America Market Value Share Analysis, by Treatment, 2022 and 2033
Figure 21: North America Market Value Share Analysis, by End-user, 2022 and 2033
Figure 22: North America Market Value Share Analysis, by Country, 2022 and 2033
Figure 23: North America Market Attractiveness Analysis, by Treatment
Figure 24: North America Market Attractiveness Analysis, by End-user
Figure 25: Europe Market Size (US$ Mn) Forecast, 2023 to 2033
Figure 26: Europe Market Attractiveness Analysis, by Country
Figure 27: Europe Market Value Share Analysis, by Treatment, 2022 and 2033
Figure 28: Europe Market Value Share Analysis, by End-user, 2022 and 2033
Figure 29: Europe Market Value Share Analysis, by Country, 2022 and 2033
Figure 30: Europe Market Attractiveness Analysis, by Treatment
Figure 31: Europe Market Attractiveness Analysis, by End-user
Figure 32: Asia Pacific Market Size (US$ Mn) Forecast, 2023 to 2033
Figure 33: Asia Pacific Market Attractiveness Analysis, by Country
Figure 34: Asia Pacific Market Value Share Analysis, by Treatment, 2022 and 2033
Figure 35: Asia Pacific Market Value Share Analysis, by End-user, 2022 and 2033
Figure 36: Asia Pacific Market Value Share Analysis, by Country, 2022 and 2033
Figure 37: Asia Pacific Market Attractiveness Analysis, by Treatment
Figure 38: Asia Pacific Market Attractiveness Analysis, by End-user
Figure 39: Latin America Market Size (US$ Mn) Forecast, 2023 to 2033
Figure 40: Latin America Market Attractiveness Analysis, by Country
Figure 41: Latin America Market Value Share Analysis, by Treatment, 2022 and 2033
Figure 42: Latin America Market Value Share Analysis, by End-user, 2022 and 2033
Figure 43: Latin America Market Value Share Analysis, by Country, 2022 and 2033
Figure 44: Latin America Market Attractiveness Analysis, by Treatment
Figure 45: Latin America Market Attractiveness Analysis, by End-user
Figure 46: Middle East & Africa Market Size (US$ Mn) Forecast, 2023 to 2033
Figure 47: Middle East & Africa Market Attractiveness Analysis, by Country
Figure 48: Middle East & Africa Market Value Share Analysis, by Treatment, 2022 and 2033
Figure 49: Middle East & Africa Market Value Share Analysis, by End-user, 2022 and 2033
Figure 50: Middle East & Africa Market Value Share Analysis, by Country, 2022 and 2033
Figure 51: Middle East & Africa Market Attractiveness Analysis, by Treatment
Figure 52: Middle East & Africa Market Attractiveness Analysis, by End-user
Figure 53: Global Basal Cell Carcinoma Market Share Analysis, by Company (2022)
Figure 54: Sun Pharmaceuticals Ltd Revenue (US$ Mn) & Y-o-Y Growth (%), 2014 to 2022
Figure 55: Sun Pharmaceuticals Ltd Breakdown of Net Sales, By Business Segments, 2022
Figure 56: Sun Pharmaceuticals Ltd Breakdown of Net Sales, by Region, 2022
Figure 57: Sun Pharmaceuticals Ltd R&D Expense (US$ Bn) & Y-o-Y Growth (%), 2015 to 2022
Figure 58: Valeant Pharmaceuticals International, Inc. Revenue (US$ Bn) and Y-o-Y Growth (%), 2018 to 2022
Figure 59: Valeant Pharmaceuticals International, Inc. Marketing and R&D Expenses, 2018 to 2022
Figure 60: Valeant Pharmaceuticals International, Inc. Breakdown of Net Sales, by Region, 2022
Figure 61: Valeant Pharmaceuticals International, Inc. Breakdown of Net Sales, by Business Segment, 2022
Figure 62: Mylan N.V. Marketing and R&D Expenses, 2018 to 2022
Figure 63: Mylan N.V. Revenue (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022
Figure 64: Mylan N.V. Breakdown of Net Sales, by Region, 2022
Figure 65: F. Hoffmann-La Roche Ltd. Revenue (US$ Bn) and Y-o-Y Growth (%), 2018 to 2022
Figure 66: F. Hoffmann-La Roche Ltd. R&D Expenses, 2018 to 2022
Figure 67: F. Hoffmann-La Roche Ltd. Breakdown of Net Sales, by Region, 2022
Figure 68: Merck & Co., Inc. Revenue (US$ Bn) & Y-o-Y Growth (%), 2018 to 2022
Figure 69: Merck & Co., Inc. Breakdown of Net Sales, by Region, 2022
Figure 70: Merck & Co., Inc. Breakdown of Net Sales, by Business Segment, 2022
Figure 71: Merck & Co., Inc. R&D Expense (US$ Bn) & Y-o-Y Growth (%), 2018 to 2022
Who worked on this report
Preview the report firsthand - request a free sample
Free SampleGet the brochure for pricing and purchase details
Download PDF